Valneva SE VALN
NASDAQ VALN
$6.89 -0.17 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Valneva SE (VALN) Change in Working Capital (2021 - 2026)

Valneva SE (VALN) posted Change in Working Capital of $20.2 million for Q1 2026, up 16442.61% sequentially from -$123388.6 in Q4 2025, and up 308.94% YoY from $4.9 million in Q1 2025.

Analysis

Valneva SE (VALN) Change in Working Capital (2021 - 2026) Analysis & Trends

Valneva SE has reported Change in Working Capital for 6 years, with the latest figure at $20.2 million in Q1 2026.

  • Quarterly Change in Working Capital rose 308.94% year-over-year to $20.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32.6 million (up 134.03% YoY) and the FY2025 annual result came in at $1.7 million, down 86.12% from the prior year.
  • Change in Working Capital climbed to $20.2 million in Q1 2026 per VALN's latest filing, from -$123388.6 in the prior quarter.
  • Over five years, Change in Working Capital peaked at $46.5 billion in Q3 2023 and troughed at -$46.6 billion in Q2 2023.
  • A 5-year average of $10.8 million and a median of -$123388.6 in 2025 frame the typical range for Change in Working Capital.
  • The widest YoY moves for Change in Working Capital: up 41843.2% in 2023, down 29580.84% in 2023.
  • Over 5 years, Change in Working Capital stood at -$51.6 million in 2022, then surged by 598.31% to $257.1 million in 2023, then slumped by 80.68% to $49.7 million in 2024, then plunged by 100.25% to -$123388.6 in 2025, then soared by 16442.61% to $20.2 million in 2026.
  • According to Business Quant data, Change in Working Capital over the past three periods registered $20.2 million, -$123388.6, and $10.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Working Cap. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Valneva SE 578.54 Mn 437.28 Mn 1.86 Mn 2.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.38 Mn
Mar 31, 2026 3,512.24
Dec 31, 2025 181,590.79
Sep 30, 2025 831,198.17
Jun 30, 2025 53,202.11
Mar 31, 2025 430,220.74
Dec 31, 2024 -524,680.34
Sep 30, 2024 1.57 Mn
Jun 30, 2024 -633,209.89
Mar 31, 2024 -574,685.37
Dec 31, 2023 747,778.24
Sep 30, 2023 -303.91 Mn
Jun 30, 2023 304.10 Mn
Mar 31, 2023 -288,728.95
Dec 31, 2022 8.42 Mn
Sep 30, 2022 -63.65 Mn
Jun 30, 2022 -93.99 Mn
Mar 31, 2022 -5.35 Mn
Dec 31, 2021 63.08 Mn
Sep 30, 2021 -4.87 Mn